UAB MIP Pharma Lietuva Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 100,994 |
| 100,994 |
| 79,371 |
| 73,548 |
| 73,548 |
| 99.93 |
| 72.82 |
| 85,300 |
| 6,450 |
| 0 |
| 92,390 |
| 2023 |
|---|
| 30,931 |
| 30,931 |
| 20,251 |
| 19,340 |
| 19,340 |
| 99.84 |
| 62.53 |
| 104,641 |
| 1,558 |
| 0 |
| 106,839 |
| 2024 |
|---|
| 38,176 |
| 38,176 |
| 29,607 |
| 28,275 |
| 28,275 |
| 99.92 |
| 74.06 |
| 132,916 |
| 6,326 |
| 0 |
| 139,882 |
Register and
explore Okredo data| 2024 |
|---|
| 38,176 |
| 38,176 |
| 29,607 |
| 28,275 |
| 28,275 |
| 99.92 |
| 74.06 |
| 132,916 |
| 6,326 |
| 0 |
| 139,882 |
Register and
explore Okredo data2024
Turnover (€)
38,176 €
23 % *
Sales per employee (€)
38,176 €23 % *
Profit before tax (€)
29,607 €46 % *
Net Profit (€)
28,275 €46 % *
Profit per employee (€)
28,275 €46 % *
Total profitability (%)
99.92 %0.08 % *
Net profitability (%)
74.06 %18.44 % *
Equity (€)
132,916 €27 % *
Amounts Payable And Liabilities (€)
6,326 €
306 % *
Non-current Assets (€)
0 €
- *
CurrentAssets (€)
139,882 €31 % *